I agree that this site is using cookies. You can find further informations here.
X
Giacchetti, S
72  results:
Search for persons X
?
1

124P Neoadjuvant durvalumab plus endocrine therapy followin..:

Verret, B. ; Lacroix-Triki, M. ; Ladoire, S....
ESMO Open.  9 (2024)  - p. 103112 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Prognostic value of EndoPredict test in patients with hormo..:

Penault-Llorca, F. ; Dalenc, F. ; Chabaud, S....
ESMO Open.  9 (2024)  5 - p. 103443 , 2024
Link: https://doi.org/10.1016/..
 
?
3

O012: Clinical utility of a simple risk assessment model fo..:

Frere, C. ; Espie, M. ; Gligorov, J....
Thrombosis Research.  175 (2019)  - p. S5 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Surgical resection versus systemic therapy for breast cance..:

Ruiz, A. ; van Hillegersberg, R. ; Siesling, S....
European Journal of Cancer.  95 (2018)  - p. 1-10 , 2018
Link: https://doi.org/10.1016/..
 
?
5

EP-1150: Preliminary results of Intra-Operative RadioTherap..:

Guillerm, S. ; Bourstyn, E. ; Itti, R....
Radiotherapy and Oncology.  123 (2017)  - p. S625 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Cancer du sein triple négatif : impact pronostique de la TE..:

Groheux, D. ; Giacchetti, S. ; Delord, M....
Médecine Nucléaire.  39 (2015)  3 - p. 256 , 2015
Link: https://doi.org/10.1016/..
 
?
7

431 Real-time pharmacokinetic (PK) results from an ongoing ..:

Lokiec, F. ; Bonneterre, J. ; Italiano, A....
European Journal of Cancer.  50 (2014)  - p. 142 , 2014
Link: https://doi.org/10.1016/..
 
?
8

Nouveautés sur les thérapies ciblées dans le cancer du sein:

Coussy, F. ; Teixeira, L. ; Giacchetti, S....
Gynécologie Obstétrique & Fertilité.  42 (2014)  11 - p. 787-794 , 2014
Link: https://doi.org/10.1016/..
 
?
9

Prognostic impact of 18F-FDG PET/CT staging and of patholog..:

Groheux, D. ; Giacchetti, S. ; Delord, M....
European Journal of Nuclear Medicine and Molecular Imaging.  42 (2014)  3 - p. 377-385 , 2014
Link: https://doi.org/10.1007/..
 
?
10

Caractérisation de tumeur à partir d'images TEP au 18F-FDG ..:

Hatt, M. ; Groheux, D. ; Martineau, A....
Médecine Nucléaire.  37 (2013)  5 - p. 144 , 2013
Link: https://doi.org/10.1016/..
 
?
11

HER2-overexpressing breast cancer: FDG uptake after two cyc..:

Groheux, D ; Giacchetti, S ; Hatt, M...
British Journal of Cancer.  109 (2013)  5 - p. 1157-1164 , 2013
Link: https://doi.org/10.1038/..
 
?
12

Challenging single- and multi-probesets gene expression sig..:

Valet, F. ; de Cremoux, P. ; Spyratos, F....
The Breast.  22 (2013)  6 - p. 1052-1059 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Prédiction de la réponse a la chimiothérapie néoadjuvante d..:

Groheux, D. ; Hatt, M. ; Martineau, A....
Médecine Nucléaire.  37 (2013)  5 - p. 137 , 2013
Link: https://doi.org/10.1016/..
 
?
14

451 Underestimation Rate of Invasive Malignancy in Atypical..:

Guyon, L. ; Hamy, A.S. ; de Roquancourt, A....
European Journal of Cancer.  48 (2012)  - p. S178 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stag..:

Groheux, D. ; Hindie, E. ; Delord, M....
JNCI Journal of the National Cancer Institute.  104 (2012)  24 - p. 1879-1887 , 2012
Link: https://doi.org/10.1093/..
 
1-15